drugset / Trial / NCT01002378

The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib

NCT01002378

Phase 1 Completed 24 enrolled Bayer
RandomizedCrossoverOpen-labelScreening

Summary

An open label, three way crossover study to determine the effect of a high fat breakfast or a low fat breakfast on the pharmacokinetics of a single dose of regorafenib.

Timeline

Start
2009-10
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Regorafenib Small molecule 160 mg Oral

Indications

No indication recorded.